IBT
International Biotechnology Trust Portfolio holdings
AUM
$297M
This Quarter Return
-0.52%
1 Year Return
+17.25%
3 Year Return
+11.14%
5 Year Return
+79.35%
10 Year Return
–
AUM
$449M
AUM Growth
+$449M
(+8.3%)
Cap. Flow
+$48.9M
Cap. Flow
% of AUM
10.89%
Top 10 Holdings %
Top 10 Hldgs %
46.73%
Holding
81
New
13
Increased
18
Reduced
10
Closed
8
Top Buys
| 1 |
Exelon
EXC
|
$9.99M |
| 2 |
Ionis Pharmaceuticals
IONS
|
$9.44M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$8.99M |
| 4 |
CRISPR Therapeutics
CRSP
|
$8.19M |
| 5 |
Amgen
AMGN
|
$5.95M |
Top Sells
Sector Composition
| 1 | Healthcare | 97.48% |
| 2 | Utilities | 2.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Exelixis
EXEL
$9.95B
| – | – |
-489,534
| Closed | -$10.3M |
|
77
Esperion Therapeutics
ESPR
$490M
| – | – |
-9,500
| Closed | -$114K |
|
78
Enanta Pharmaceuticals
ENTA
$189M
| – | – |
-40,000
| Closed | -$2.26M |
|
|
BLUE
79
DELISTED
bluebird bio
BLUE
| – | – |
-849
| Closed | -$210K |
|
80
Axsome Therapeutics
AXSM
$6.09B
| – | – |
-14,000
| Closed | -$461K |
|
|
ALLK
81
DELISTED
Allakos
ALLK
| – | – |
-15,700
| Closed | -$1.66M |
|